39002609|t|Unraveling the relationship among insulin resistance, IGF-1, and amyloid-beta 1-40: Is the definition of type 3 diabetes applicable in the cardiovascular field?
39002609|a|The concept of "type 3 diabetes" has emerged to define alterations in glucose metabolism that predispose individuals to the development of Alzheimer's disease (AD). Novel evidence suggests that changes in the insulin/insulin-like growth factor 1 (IGF-1)/growth hormone (GH) axis, which are characteristic of Diabetes Mellitus, are one of the major factors contributing to excessive amyloid-beta (Abeta) production and neurodegenerative processes in AD. Moreover, molecular findings suggest that insulin resistance and dysregulated IGF-1 signaling promote atherosclerosis via endothelial dysfunction and a pro-inflammatory state. As the pathophysiological role of Abeta1-40 in patients with cardiovascular disease has attracted attention due to its involvement in plaque formation and destabilization, it is of great interest to explore whether a paradigm similar to that in AD exists in the cardiovascular field. Therefore, this review aims to elucidate the intricate interplay between insulin resistance, IGF-1, and Abeta1-40 in the cardiovascular system and assess the applicability of the type 3 diabetes concept. Understanding these relationships may offer novel therapeutic targets and diagnostic strategies to mitigate cardiovascular risk in patients with insulin resistance and dysregulated IGF-1 signaling.
39002609	34	52	insulin resistance	Disease	MESH:D007333
39002609	54	59	IGF-1	Gene	3479
39002609	105	120	type 3 diabetes	Disease	MESH:C566342
39002609	177	192	type 3 diabetes	Disease	MESH:C566342
39002609	231	238	glucose	Chemical	MESH:D005947
39002609	300	319	Alzheimer's disease	Disease	MESH:D000544
39002609	321	323	AD	Disease	MESH:D000544
39002609	370	377	insulin	Gene	3630
39002609	378	406	insulin-like growth factor 1	Gene	3479
39002609	408	413	IGF-1	Gene	3479
39002609	415	429	growth hormone	Gene	2688
39002609	431	433	GH	Gene	8836
39002609	469	486	Diabetes Mellitus	Disease	MESH:D003920
39002609	543	555	amyloid-beta	Gene	351
39002609	557	562	Abeta	Gene	351
39002609	610	612	AD	Disease	MESH:D000544
39002609	656	674	insulin resistance	Disease	MESH:D007333
39002609	692	697	IGF-1	Gene	3479
39002609	716	731	atherosclerosis	Disease	MESH:D050197
39002609	736	759	endothelial dysfunction	Disease	MESH:D014652
39002609	770	782	inflammatory	Disease	MESH:D007249
39002609	837	845	patients	Species	9606
39002609	851	873	cardiovascular disease	Disease	MESH:D002318
39002609	1035	1037	AD	Disease	MESH:D000544
39002609	1147	1165	insulin resistance	Disease	MESH:D007333
39002609	1167	1172	IGF-1	Gene	3479
39002609	1253	1268	type 3 diabetes	Disease	MESH:C566342
39002609	1409	1417	patients	Species	9606
39002609	1423	1441	insulin resistance	Disease	MESH:D007333
39002609	1459	1464	IGF-1	Gene	3479
39002609	Association	MESH:D050197	3479
39002609	Association	MESH:D007249	3479
39002609	Association	MESH:D014652	3479
39002609	Association	MESH:D003920	8836
39002609	Association	MESH:D007333	3479
39002609	Association	MESH:D003920	2688
39002609	Association	MESH:D000544	351
39002609	Association	3479	351
39002609	Association	MESH:D003920	3630
39002609	Association	MESH:D000544	3479
39002609	Association	2688	351
39002609	Association	351	3630
39002609	Association	MESH:D005947	MESH:D000544
39002609	Positive_Correlation	MESH:D003920	351
39002609	Association	MESH:D000544	2688
39002609	Association	MESH:D003920	3479
39002609	Association	MESH:D005947	MESH:C566342
39002609	Association	MESH:D000544	3630

